Statistical Considerations for Small Patient Populations in Orphan Drug Trials
Statistical Considerations for Small Patient Populations in Orphan Drug Trials Designing Statistically Robust Orphan Drug Trials with Small Patient Populations Introduction: The Statistical Dilemma in Rare Disease Trials Clinical trials for orphan drugs often involve extremely small patient populations, which introduces unique statistical challenges not typically encountered in larger studies. These include limitations in statistical…
Read More “Statistical Considerations for Small Patient Populations in Orphan Drug Trials” »